Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors

Louis Alexander1, Lisa Cuchura, B Joyce Simpson

  • 1Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT 06520, USA. louis.alexander@yale.edu

Insights

Host and viral factors, not just limited treatment, contribute to slow human immunodeficiency virus type 1 (HIV-1) progression in children. Genetic factors like CCR2 polymorphism and viral mutations appear crucial for long-term non-progressive HIV-1 infection.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Immunogenetics

Background:

  • Limited data exists on factors influencing varying clinical progression rates in pediatric human immunodeficiency virus type 1 (HIV-1) infection.
  • Understanding these determinants is crucial for managing HIV-1 in children.

Purpose of the Study:

  • To investigate whether viral and host factors known to be associated with nonprogressive HIV-1 infection in adults are also present in children with minimal disease progression.
  • To identify potential mechanisms contributing to long-term non-progressive HIV-1 infection in vertically infected youths receiving minimal antiretroviral therapy.

Main Methods:

  • Characterization of 5 vertically HIV-1 infected youths (ages 12-18) with minimal disease progression and low antiretroviral exposure.
  • Analysis of plasma HIV-1 RNA loads, CD4 T-lymphocyte counts/percentages.
  • Sequencing of predominant HIV-1 strains to identify resistance markers and replication-inhibiting mutations (Gag, Vif).
  • Genotyping for CCR2 polymorphism (64I) and analysis of histocompatibility leukocyte antigen (HLA) phenotypes (DQ1, DR/DQ1).

Main Results:

  • All 5 long-term survivors maintained low HIV-1 RNA levels and normal CD4 counts.
  • 4 out of 5 harbored HIV-1 with therapy resistance markers; 2 had viral isolates with Gag/Vif insertions inhibiting replication.
  • 2 individuals were heterozygous for CCR2 64I polymorphism, associated with slower AIDS progression in adults.
  • All 5 expressed HLA DQ1, with 2 showing unusual DR/DQ1 phenotypes.

Conclusions:

  • Limited antiretroviral therapy alone does not explain the benign clinical status of these long-term survivors.
  • Host genetic factors (e.g., CCR2 polymorphism, HLA types) and viral characteristics (e.g., reduced replicative capacity) likely contribute to controlling HIV-1 progression.
  • No single virologic or host factor fully explains the non-progressive phenotype in all cases, suggesting a multifactorial etiology similar to adults.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...